miR-660-5p-loaded M2 macrophages-derived exosomes augment hepatocellular carcinoma development through regulating KLF3

被引:33
|
作者
Tian, BingZhang [1 ]
Zhou, Lixue [1 ]
Wang, Jun [1 ]
Yang, Pingzhou [1 ]
机构
[1] Hunan Prov Peoples Hosp, Dept Hepatobiliary Surg, 61 Jiefang West Rd, Changsha 410005, Peoples R China
关键词
Hepatocellular carcinoma; MicroRNA-660-5p; Kruppel-like factor 3; M2 macrophages-derived exosomes; Tumorigenesis; TUMOR-GROWTH; PROMOTES; CANCER; CELLS;
D O I
10.1016/j.intimp.2021.108157
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: M2 macrophages (M2) can affect tumor development by secreting various cytokines, including exosomes (Exo). Herein, we intended to explore how microRNA (miR)-660-5p-modified M2-Exo affected hepatocellular carcinoma (HCC) development through regulating Kruppel-like factor 3 (KLF3). Methods: miR-660-5p and KLF3 levels were first measured in clinical HCC tissues. A miR-targeted relation was explored between miR-660-5p and KLF3. M2-Exo were modified by miR-660-5p-related oligonucleotides and cocultured with HepG2 cells to determine their effects on cell proliferation, colony formation, invasion, migration, apoptosis and epithelial-mesenchymal transition (EMT). Xenografted tumors were collected from mice to further verify the in vitro results. Results: Higher miR-660-5p and lower KLF3 levels were examined in HCC. KLF3 was targeted by miR-660-5p. Upregulated miR-660-5p-modified M2-Exo boosted the grwoth and EMT of HepG2 cells, but this effect was impaired by overexpression of KLF3. miR-660-5p-loaded M2-Exo enhanced tumorigenic ability of HCC cells in mice. On the contrary, down-regulated miR-660-5p reduced M2-Exo-mediated promotion of growth of HCC cells in vitro and in vivo. Conclusion: Our study summarizes that miR-660-5p-loaded M2-Exo augment HCC development through downregulating KLF3.
引用
收藏
页数:9
相关论文
共 50 条
  • [2] microRNA-155-3p delivered by M2 macrophages-derived exosomes enhances the progression of medulloblastoma through regulation of WDR82
    Song, Li
    Luan, Bin
    Xu, Qingrong
    Shi, Ruihe
    Wang, Xiufang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [3] microRNA-155-3p delivered by M2 macrophages-derived exosomes enhances the progression of medulloblastoma through regulation of WDR82
    Li Song
    Bin Luan
    Qingrong Xu
    Ruihe Shi
    Xiufang Wang
    Journal of Translational Medicine, 20
  • [4] Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways
    Li, Wenxiao
    Xin, Xiaowen
    Li, Xiujun
    Geng, Jianli
    Sun, Yunfu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [5] M1 macrophages-derived exosomes miR-34c-5p regulates interstitial cells of Cajal through targeting SCF
    Xu, Su
    Zhai, Jinhai
    Xu, Ke
    Zuo, Xingguo
    Wu, Chenghua
    Lin, Tao
    Zeng, Li
    JOURNAL OF BIOSCIENCES, 2021, 46 (04)
  • [6] M1 macrophages-derived exosomes miR-34c-5p regulates interstitial cells of Cajal through targeting SCF
    Su Xu
    Jinhai Zhai
    Ke Xu
    Xingguo Zuo
    Chenghua Wu
    Tao Lin
    Li Zeng
    Journal of Biosciences, 2021, 46
  • [7] M2 Macrophage-Derived Exosomes Inhibit Apoptosis of HUVEC Cell through Regulating miR-221-3p Expression
    Cheng, Xiandong
    Zhou, Hong
    Zhou, Ying
    Song, Cheng
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [8] Tumor-derived exosomes promote macrophages M2 polarization through miR-1-3p and regulate the progression of liver cancer
    Gu, Weiwei
    Yang, Yang
    Liu, Jiajia
    Xue, Jianhua
    Zhao, Hui
    Mao, Lingyun
    Zhao, Suming
    MOLECULAR IMMUNOLOGY, 2023, 162 : 64 - 73
  • [9] M2 Macrophages-Derived Exosomal miRNA-23a-3p Promotes the Progression of Oral Squamous Cell Carcinoma by Targeting PTEN
    Li, Jun
    Bao, Yongjie
    Peng, Sisi
    Jiang, Chao
    Zhu, Luying
    Zou, Sihai
    Xu, Jie
    Li, Yong
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (06) : 4936 - 4947
  • [10] M2 macrophage exosomes promote resistance to sorafenib in hepatocellular carcinoma cells via miR-200c-3p
    Li, Wenhua
    Zhao, Bin
    Wang, Qianwen
    Lu, Junxia
    Wu, Xiangwei
    Chen, Xueling
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 139